Company / Capital Expenditures
Minerva Neurosciences, Inc. Capital Expenditures History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$16.3K
FY2023
5-year range
$16.3K / $16.3K
FY2019-FY2023
Trend
+0.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $52,400 to $16,326 over the past 5 years.
Based on SEC 10-K filings.
$16,326 in FY2023 with a 5-year CAGR of -20.8%.
Declined from $52,400 to $16,326 over the past 5 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -20.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -20.8%, indicating a declining trend.
- In FY2023, capital expenditures increased 0.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $16.3K | +0.0% |
| FY2022 | $16.3K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $52.4K | +0.0% |
| FY2017 | $52.4K | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026